Sometimes biotech really feels like an industry in danger of being left behind. Take last Friday afternoon for example. I was at a networking reception at the University of Washington, chatting with undergraduates from all kinds of engineering fields about the job market. People were finding jobs, but nothing much to brag about, until I … Continue reading “Considering a Career in Biotech? How About Trying Computer Science Instead”
Category: San Diego
Ampla Pharmaceuticals Lands $1,467,898 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aaa49914-63f0-4b3a-a735-0f98712cc967&Preview=1 Date 5/2/2011 Company Name Ampla Pharmaceuticals Mailing Address 5410 La Jolla Blvd La Jolla, CA 92037 Company Description The company operates as a pharmaceutical company. Website Undisclosed Transaction Type Venture Equity Transaction Amount $1,467,898 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A Terms Venture Investor … Continue reading “Ampla Pharmaceuticals Lands $1,467,898 New Funding”
Goin’ Mobile: VoxOx Launches iPhone App with International Calling Feature
San Diego-based VoxOx, which provides a free communications service based on voice over Internet (VoIP) technology, hopes to make a big splash today with the release of its VoxOx Call for iPhone—the startup’s first mobile app. When VoxOx debuted three years ago, users could download a free application to their desktop, enabling consumers to combine … Continue reading “Goin’ Mobile: VoxOx Launches iPhone App with International Calling Feature”
From Smartphones to Smart Spaces: SRI’s Vision of Computer Evolution
If the future is here but unevenly distributed, as William Gibson said, then where is it concentrated? One place, certainly, is the contract research giant SRI International. Created by Stanford University in 1946, it’s the organization we have to thank for inventions like automated check processing, the computer mouse, hypertext, the ARPANET (which evolved into … Continue reading “From Smartphones to Smart Spaces: SRI’s Vision of Computer Evolution”
Vertex Wins FDA Panel’s Recommendation for New Hepatitis C Drug
Vertex Pharmaceuticals’ bid for FDA approval of its new drug for hepatitis C has been treated by most observers as a slam dunk, and the company, as expected, nailed its high percentage shot on goal today. Cambridge, MA-based Vertex (NASDAQ: [[ticker:VRTX]]) received a unanimous 18-0 endorsement from an FDA advisory panel, which said the company’s … Continue reading “Vertex Wins FDA Panel’s Recommendation for New Hepatitis C Drug”
Nootkatone, So A-peeling in Grapefruit, is Repellent to Mosquitoes and Ticks
When I profiled Allylix last summer, CEO Carolyn Fritz explained how the San Diego startup was using genetically engineered yeast and proprietary fermentation technology to produce specialized “aroma chemicals” for the $1.9 billion flavor and fragrance market. The company’s first product was a compound with a keen grapefruit taste and smell called nootkatone, a flavor … Continue reading “Nootkatone, So A-peeling in Grapefruit, is Repellent to Mosquitoes and Ticks”
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News
Is sentiment coming together to push for FDA regulatory reform? Luke’s BioBeat column described industry efforts to shake up the FDA, and U.S. Rep. Darell Issa convened a hearing in San Diego last to collect life sciences testimony on needed reforms. We have details on all that and more. —In a run-up to an FDA … Continue reading “Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News”
LegalZoom Lands New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=d9c8338f-1300-4de8-bc20-9fe3817891f0&Preview=1 Date 4/28/2011 Company Name LegalZoom Mailing Address 7083 Hollywood Blvd. Los Angeles, CA 90028 Company Description The company operates a website that provides legal forms and other resources. Website http://www.legalzoom.com Transaction Type Venture Equity Transaction Amount Undisclosed Transaction Round Undisclosed Proceeds Purposes Specific proceeds purposes were not disclosed. M&A Terms Venture … Continue reading “LegalZoom Lands New Funding”
VMIX Releases “Vidcinity” iPad App
San Diego-based VMIX, which has revised its strategy to emphasize social media, today unveiled a free Vidcinity iPad 2 app that allows users to create and broadcast video linked to a specific location, and enables users to find other location-specific videos. VMIX, which announced last month that it was offering video rentals on Facebook, says … Continue reading “VMIX Releases “Vidcinity” iPad App”
San Diego’s Polaris Moves to Late-Stage Test of Drug for Liver Cancer and Other “Arginine-Dependant” Tumors
Bor-Wen Wu says he had the North Star in mind in 2006 when he founded San Diego’s Polaris Group, a small holding company with a promising lead drug candidate for treating liver cancer, malignant melanoma, and other related cancers. As an explorer in science, Wu says, “I need a North Star to tell me where … Continue reading “San Diego’s Polaris Moves to Late-Stage Test of Drug for Liver Cancer and Other “Arginine-Dependant” Tumors”
Service-Now Names Software Industry Veteran Frank Slootman as CEO
When I met in January with Service-now.com founding CEO Fred Luddy, he said the company that provides software-as-a-service for IT management has enough momentum to carry it through an IPO. Today, if I’m reading the tea leaves correctly, the San Diego company took an important preliminary step in that process by naming Bay Area software … Continue reading “Service-Now Names Software Industry Veteran Frank Slootman as CEO”
FDA Says Vertex Drug a Wee Bit More Effective Than Advertised; Stock Climbs
The FDA often finds a few flies in the ointment when it digs through new drug applications, but in the case of Cambridge, MA-based Vertex Pharmaceuticals (NASDAQ: [[ticker:VRTX]]), its new hepatitis C drug looks a bit better under close scrutiny. Shares of Vertex climbed more than 10 percent after FDA briefing documents on the new … Continue reading “FDA Says Vertex Drug a Wee Bit More Effective Than Advertised; Stock Climbs”
Illumina Joins $41M Bet on Oxford Nanopore
San Diego-based Illumina (NASDAQ: [[ticker:ILMN]]), the world’s biggest maker of high-speed gene sequencing machines, has made another equity investment in U.K-based Oxford Nanpore. Oxford said today it has raised $41 million (25 million pounds) from Lansdowne Partners, IP Group, Invesco Perpetual, Redmile Group, Illumina and other undisclosed investors. Illumina first invested in Oxford, and its … Continue reading “Illumina Joins $41M Bet on Oxford Nanopore”
San Diego’s Q1 VC Activity Might Not Be So Bad After All
The MoneyTree snapshot of first-quarter venture activity that we reported 10 days ago showed a dire decline in venture investments in the San Diego region so far this year. But the local picture looks a lot better in data for the same period that came in recently from Dow Jones VentureSource. The information from Dow … Continue reading “San Diego’s Q1 VC Activity Might Not Be So Bad After All”
Smartphone Demand Powers Qualcomm Results, Soitec Makes Case for Solar Project, West Wireless Recasts Its Mission, & More San Diego BizTech News
The director of the San Diego Supercomputer Center says digital information is increasing exponentially, which is helping to fuel demand for smartphones and tablet computers, and that is driving Qualcomm’s financial performance. We’ve got a week’s worth of details for you here. —San Diego’s Qualcomm (NASDAQ: [[ticker:QCOM]]) is on a phenomenal tear. Driven by increased … Continue reading “Smartphone Demand Powers Qualcomm Results, Soitec Makes Case for Solar Project, West Wireless Recasts Its Mission, & More San Diego BizTech News”
Vertex, Merck Step Up to the Public Stage With Hepatitis C Drugs This Week
Vertex Pharmaceuticals is heading down the home stretch in its bid to transform treatment of hepatitis C, and this week the public will get an up-close look at the risks and benefits of its drug that could change the standard of care for millions of people. Cambridge, MA-based Vertex (NASDAQ: [[ticker:VRTX]]) will have its big … Continue reading “Vertex, Merck Step Up to the Public Stage With Hepatitis C Drugs This Week”
VCs Turn Up The Heat on FDA to Get Faster, More Predictable
The FDA felt the heat in the 1990s when AIDS activists marched in the streets, shouting about how bureaucratic foot-dragging meant that patients died while waiting for approvals of experimental drugs. The FDA listened. It started clearing more new drugs for sale, and completing safety and effectiveness reviews faster than before. Now it’s venture capitalists, … Continue reading “VCs Turn Up The Heat on FDA to Get Faster, More Predictable”
A Roundtable with Former FDA Chief Counsel Gerald Masodi
Biocom has organized this event, which offers an opportunity to have a casual roundtable conversation about FDA-related issues with former FDA Chief Counsel Jerry Masoudi. During his tenure as chief counsel to the FDA, Masoudi was responsible for supervising all aspects of the FDA’s work, including FDA involvement in civil and criminal litigation and investigations, … Continue reading “A Roundtable with Former FDA Chief Counsel Gerald Masodi”
Reducing Risk in Drug Candidate Selection and Development
Among the myriad of questions to consider in designating a compound a “lead drug candidate,” one of the most overlooked is the question of “druggability.” Druggability refers to the physical and chemical stability of the molecule and the ability to manufacture the compound as a drug substance and as a formulated drug product. Alongside intellectual … Continue reading “Reducing Risk in Drug Candidate Selection and Development”
What Drives Buyouts of Medical Devices
Acquisitions continue to dominate medical device industry news. Is this a viable strategy for your company? Biocom has organized a candid discussion from both sides of the deal. Hear what the industry leaders are looking for in a potential acquisition, and what the steps are leading to a deal from their perspective. More online information … Continue reading “What Drives Buyouts of Medical Devices”
Employment Law for Early Stage Companies
With California’s unique employment laws, every new hire can result in large-scale liabilities if a company does not have ongoing proper compliance and monitoring. Because this level of supervision can be costly and consume management’s time and attention, early stage companies frequently find themselves unprepared to cope with employee challenges some learn to do so … Continue reading “Employment Law for Early Stage Companies”
Leasing 101: Tools for Saving More Money and Reducing Risk
Because facilities costs are often the second-largest expense item for most companies, (after payroll), it is crucial to make the most of your facilities lease negotiations. In this workshop, we will talk about the current state of the economy and specifically the current state of the real estate market in San Diego County and give … Continue reading “Leasing 101: Tools for Saving More Money and Reducing Risk”
Raising Capital from Angels and VCs
Raising capital is difficult under normal conditions, and the continuing economic slowdown isn’t making life any easier for San Diego startups. Come hear our expert panel share and discuss views on the current state of venture capital and angel investing in San Diego and other key innovation centers. Learn about current deal terms, valuation issues, … Continue reading “Raising Capital from Angels and VCs”
Renewable Energy and the Greening of the U.S. Navy—and the Ports of San Diego, Long Beach, and Los Angeles
The U.S. Navy has established ambitious goals to reduce fossil fuel usage and invest in alternative energy research and projects so that by 2020 half of all the energy used—both afloat and ashore—is supposed to come from alternative sources. Is this goal even attainable? The Maritime Alliance has organized an all-day conference to explore the … Continue reading “Renewable Energy and the Greening of the U.S. Navy—and the Ports of San Diego, Long Beach, and Los Angeles”
Could a Game Be the Answer to Your E-mail Woes?
E-mail is the great savior and scourge of our time. We couldn’t get much done without it. Yet as regular readers know, I have an ongoing feud with my inbox. I’ve declared e-mail bankruptcy (twice), I’ve adopted tools like Taskforce that help turn e-mails into to-do list items, and I’ve tried filtering options like Gmail’s … Continue reading “Could a Game Be the Answer to Your E-mail Woes?”
West Wireless Repositions Itself as an Impartial Arbiter, Amylin Makes Headway in Europe, VCs Debate Viability of Venture-Backed Biotech, & More San Diego Life Sciences News
While overall venture funding in San Diego was off dramatically during the first quarter, three life sciences deals disclosed last week suggest that a turnaround is underway. We’ve got those details and more. —By making a few management changes, shedding some commercial initiatives, and distancing itself from Qualcomm (NASDAQ: [[ticker:QCOM]]), San Diego’s West Wireless Health … Continue reading “West Wireless Repositions Itself as an Impartial Arbiter, Amylin Makes Headway in Europe, VCs Debate Viability of Venture-Backed Biotech, & More San Diego Life Sciences News”
West Wireless Health Institute Distances Itself from Qualcomm, Seeks to Recast its Role
When the West Wireless Health Institute named Don Casey as its first CEO last year, the San Diego nonprofit said the former Johnson & Johnson executive was hired to drive development of the institute as “a world-class research organization focused on accelerating wireless health innovations, technology incubation, advocacy and education.” Today the institute is describing … Continue reading “West Wireless Health Institute Distances Itself from Qualcomm, Seeks to Recast its Role”
Triangulating VC Activity: Third Survey Shows Q1 Increase in Invested Capital
Another survey on venture capital activity during the first quarter shows that venture investors put $6.4 billion into 661 startups nationwide. That’s a 35 percent increase in capital and a 5 percent rise in deals, according to the report from Dow Jones VentureSource. It’s the third survey to show a substantial increase in the amount … Continue reading “Triangulating VC Activity: Third Survey Shows Q1 Increase in Invested Capital”
Amira Drug Gets Orphan Status
The U.S. Food and Drug Administration has granted orphan drug designation to AM152, the lead drug candidate under development at San Diego’s Amira Pharmaceuticals for treating idiopathic pulmonary fibrosis, a lung disease that makes it difficult to breathe. In a statement yesterday, the company says the designation provides a seven-year period of market exclusivity and … Continue reading “Amira Drug Gets Orphan Status”
Tracon Raises $14M to Advance Cancer Drug
San Diego’s Tracon Pharmaceuticals says today it has raised $14 million of a planned $22 million round of venture capital needed to advance development of TRC105, a promising therapeutic that inhibits the growth of new blood vessels that supply tumors. The National Cancer Institute also is supporting the company’s research and development, which includes ongoing … Continue reading “Tracon Raises $14M to Advance Cancer Drug”
FDA Clears Gen-Probe for Trichomonas Test
San Diego-based Gen-Probe (NASDAQ: [[ticker:GPRO]]) says today the FDA has cleared its nucleic acid amplification test to detect the sexually transmitted infection Trichomonas vaginalis for use in the United States. Gen-Probe says its Aptima assay is the first such test to be approved specifically for Trichomonas vaginalis, which is the most common curable sexually transmitted … Continue reading “FDA Clears Gen-Probe for Trichomonas Test”
Lebovitz Named as Venture Partner at DFJ Mercury
DFJ Mercury, a Houston-based seed-stage venture firm, has promoted venture advisor Russ Lebovitz to venture partner in San Diego and Houston, according to a report in PE Hub. Lebovitz is the CEO of Marval Biosciences, a DFJ Mercury portfolio company with offices in both Houston and La Jolla, CA, and the founder and chairman of … Continue reading “Lebovitz Named as Venture Partner at DFJ Mercury”
Fate Therapeutics Receives $1,000,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3e04fb64-014e-4b5e-b5c7-17fb520e3ee4&Preview=1 Date 4/20/2011 Company Name Fate Therapeutics Mailing Address 3535 General Atomics Court San Diego, CA 92121 Company Description The company’s revolutionary platform focuses on both regenerative and reprogramming medicine. Fate’s regenerative medicine platform involves developing drugs that awaken adult stem cells in the body to repair damaged cells and tissues. Fate’s … Continue reading “Fate Therapeutics Receives $1,000,000 New Financing”
ScoreBig Secures $14,116,381 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c296770b-aad4-471f-b109-3e20046271ec&Preview=1 Date 4/20/2011 Company Name ScoreBig Mailing Address 1800 N. Highland Ave. Los Angeles, CA 90028 Company Description The company provides unsold ticket liquidation services. Website http://www.scorebig.com Transaction Type Venture Equity Transaction Amount $14,116,381 Transaction Round Undisclosed Proceeds Purposes Proceeds purposes were not disclosed. SEC regulatory filing. M&A Terms Venture Investor Undisclosed
HipGeo Secures $500,000 New Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=c4989318-6277-4c9b-9de1-674c69cc37e2&Preview=1 Date 4/20/2011 Company Name HipGeo Mailing Address 1435 N. Harbor Blvd. Fullerton, CA 92835 Company Description HipGeo is a developer of location-aware platforms including smartphone apps, websites and APIs that automatically create a record of the places users go and how they get there. Website http://www.hipgeo.com Transaction Type Venture Equity Transaction … Continue reading “HipGeo Secures $500,000 New Funding Round”
Sangart Garners $50,000,000 New Funding
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=6e870e93-7f7a-45cd-b783-c47d6c2be15b&Preview=1 Date 4/20/2011 Company Name Sangart Mailing Address 6175 Lusk Blvd San Diego, CA 92121 Company Description Sangart, Inc. is a biopharmaceutical company focused on the research, development and commercialization of oxygen transport agents. Website http://www.sangart.com Transaction Type Venture Equity Transaction Amount $50,000,000 Transaction Round Undisclosed Proceeds Purposes This series G funding … Continue reading “Sangart Garners $50,000,000 New Funding”
MyLife Acquires CitizenLocal.com for Undisclosed Sum
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=040cecc9-c084-425f-88b1-2dde3f742abb&Preview=1 Date 4/20/2011 Company Name CitizenLocal.com Mailing Address 2822 Whispering Trail Irvine, CA 92602 Company Description CitizenLocal is a unique collective buying site that features amazing deals on the best stuff to do, see, eat, and buy in your neighborhood. Our Deal Gurus create fresh exciting deals with local businesses that are … Continue reading “MyLife Acquires CitizenLocal.com for Undisclosed Sum”
Awarepoint Buys Patient Care Technology Systems
San Diego’ Awarepoint, which developed wireless tags and a computerized tracking system to help hospitals and healthcare providers keep track of ventilators and other equipment, has acquired Patient Care Technology Systems, a workflow software developer in Charlotte, N.C. Financial terms of the deal were not disclosed. Awarepoint has installed its asset tracking technology in 93 … Continue reading “Awarepoint Buys Patient Care Technology Systems”
Sangart Gets $50M Infusion for Oxygen-Carrying Blood Adjunct
San Diego-based Sangart, which has been developing an oxygen-carrying compound to counter blood loss in traumatic injuries, says today it has raised more than $50 million in a Series G round of new equity funding. That’s a big deal these days in San Diego, which raised a total of slightly more than $100 million in … Continue reading “Sangart Gets $50M Infusion for Oxygen-Carrying Blood Adjunct”
Four Kinds of Startups
Since part of my job at Redstar Ventures is to meet as many entrepreneurs as possible who might want to co-found a startup with us, I’ve swilled plenty of coffee at Voltage and Peet’s swapping ideas with many a bright, passionate, and inventive entrepreneur. Somewhere into my second gallon of cappuccino, I began to notice … Continue reading “Four Kinds of Startups”
Solar Sell: Soitec CEO Argues Case for its Advanced Solar Technology in San Diego
The French semiconductor manufacturer Soitec generated headlines in San Diego last month when it said it has been working with Tenaska Solar Ventures to develop a 150-megawatt solar plant in the desert east of San Diego—at an estimated cost of $500 million. To support the project Soitec also revealed plans to build a factory somewhere … Continue reading “Solar Sell: Soitec CEO Argues Case for its Advanced Solar Technology in San Diego”
TreatFeed Secures $5,400,000 New Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=416368ad-b397-4003-8b13-c97afc8c2316&Preview=1 Date 4/19/2011 Company Name TreatFeed Mailing Address 10203 Santa Monica Blvd. Los Angeles, CA 90067 Company Description TreatFeed is the first multi-level marketing (MLM) driven shopping application that provides its members a way to benefit from their ‘word-of-mouth’. TreatFeed’s Social Tree commercializes ‘word-of-mouth’ marketing, helping members turn their enthusiasm for sharing … Continue reading “TreatFeed Secures $5,400,000 New Round”
Regulus Names Chief Scientist
San Diego-based Regulus Therapeutics, the developer of mircoRNA therapies, said today it has named Neil Gibson as its new chief scientific officer. Gibson was most recently the chief scientific officer and oncology therapeutics head at Pfizer’s oncology research unit in La Jolla, CA. Gibson replaces Peter Linsley, who left last month to join Bothell, WA-based … Continue reading “Regulus Names Chief Scientist”
CoDa Therapeutics Adds $19M Round, Led by Domain, to Pursue Diabetes Complication
San Diego-based CoDa Therapeutics isn’t the biggest name in the local diabetes R&D business, but today it has reloaded with a sizable amount of cash to test its idea for treating a common complication of the disease. CoDa, which also has operations in Auckland, New Zealand, said today it has secured a $19 million Series … Continue reading “CoDa Therapeutics Adds $19M Round, Led by Domain, to Pursue Diabetes Complication”
San Diego VC Activity Falls 55 Percent, Ford Adopts Focus as EV “Tech Platform,” Verve Raises $3.5M, & More San Diego BizTech News
While venture capital activity increased nationwide during the first quarter that ended in March, VC investing in San Diego fell to its lowest level since the first quarter of 2009. Our roundup of that and the rest of last week’s tech news begins now. —Data on first-quarter venture capital activity arrived separately from New York-based … Continue reading “San Diego VC Activity Falls 55 Percent, Ford Adopts Focus as EV “Tech Platform,” Verve Raises $3.5M, & More San Diego BizTech News”
Biotech’s Missed Opportunity: Small-Town and Rural America
The biotech and pharmaceutical industry is full of people who went to the top universities, live in the fanciest neighborhoods, and work for brand-name companies. But this industry needs to start thinking more about millions of people who are mostly an afterthought today. I’m talking about people who live in America’s small cities and rural … Continue reading “Biotech’s Missed Opportunity: Small-Town and Rural America”
In This Corner: Kinsella & More Vs. Hutton & Samuels on Venture Biotech
Avalon Ventures founder Kevin Kinsella was practically spoiling for a fight in February, when he called out the pharmaceutical industry for many instances of what he called “short-sighted, brass-knuckle negotiating tactics.” Pharma’s “bad behavior” had Kinsella questioning whether “this partnership between Big Pharma and biotech can really continue.” Kinsella’s bill of particulars, which includes buyout … Continue reading “In This Corner: Kinsella & More Vs. Hutton & Samuels on Venture Biotech”
CoDa Therapeutics Receives $19,200,000 Series B Funding Round
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=53296e7c-7b50-4a9f-b7d2-5f8a36cb8a86&Preview=1 Date 4/18/2011 Company Name CoDa Therapeutics Mailing Address 10505 Sorrento Valley Road San Diego, CA 92121 Company Description CoDa Therapeutics, Inc. is a San Diego-based pharmaceutical company focused on the development and commercialization of wound care therapeutics based on gap junction modulation. Website http://www.codatherapeutics.com Transaction Type Venture Equity Transaction Amount $19,200,000 … Continue reading “CoDa Therapeutics Receives $19,200,000 Series B Funding Round”
Lingospot Obtains $750,000 New Financing
Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5e214e19-0f70-409b-935d-a55e78cf8abc&Preview=1 Date 4/18/2011 Company Name Lingospot Mailing Address 1434 Westwood Blvd. Los Angeles, CA 90024 Company Description Lingospot was founded in Los Angeles, CA in late 2006 with the vision of intelligently using technology to help the modern online editor be more responsive to a changing and more demanding environment. Website http://corp.lingospot.com … Continue reading “Lingospot Obtains $750,000 New Financing”
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug
Amylin Pharmaceuticals and its partners, Eli Lilly and Alkermes, have had a rough time in their quest to market the first once-weekly injectable drug for diabetes patients in the U.S. But they have found a more sympathetic set of ears in Europe. San Diego-based Amylin, along with Lilly and Waltham, MA-based Alkermes, said today that … Continue reading “Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug”